title: Transdermal scopolamine use for post-rhytidectomy sialocele.
abstract: BACKGROUND
  Post-rhytidectomy sialocele is a rare complication. The usual treatment uses prolonged drainage. The use of antisialogogues has been described previously, but has potential side effects. Transdermal scopolamine SCOPODERM TTS is indicated for the prevention of motion sickness and also has antisialogugue action.
  
  
  METHODS
  An interventional case report is presented.
  
  
  RESULTS
  The application of transdermal scopolamine SCOPODERM TTS resulted in resolution of a post-rhytidectomy sialocele within 6 days.
  
  
  CONCLUSIONS
  Transdermal scopolamine delivery should be considered as an option for the treatment of post-rhytidectomy parotid fistulas.
authors.affiliation: Department of Plastic and Reconstructive Surgery, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheba, Israel. olapid@bgumail.bgu.ac.il
authors.forename: Oren
authors.initials: O
authors.lastname: Lapid
authors.forename: Yuval
authors.initials: Y
authors.lastname: Kreiger
authors.forename: Amiram
authors.initials: A
authors.lastname: Sagi
mesh_terms: D000279:Administration, Cutaneous; D005260:Female; D005402:Fistula / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D010305:Parotid Diseases / Q000209:etiology / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D015361:Rhytidoplasty / Q000009:adverse effects* / Q000534:rehabilitation; D012472:Salivation / Q000187:drug effects*; D012601:Scopolamine / Q000008:administration & dosage*; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018727:Muscarinic Antagonists; D012601:Scopolamine